DBV Technologies

DBVT NASDAQ Santé & Biotech Europe US23306J1016
19.87 $
5.38 %

Société biotechnologique française développant des immunothérapies innovantes pour le traitement des allergies.

Performance & Momentum

6 Months 39.44 %
1 Year 122.01 %
3 Years 557.95 %
5 Years 53.55 %

Similar stocks to DBV Technologies

Anantys Community

Be the first to share your analysis on DBV Technologies.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases